Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-10-26
|
pubmed:abstractText |
The expression of cell surface antigens of the spontaneous transplantable M3-murine tumour was studied by means of the monoclonal antibody (MAb) B2C114 which recognizes the human blood group-A carbohydrate antigen. Following radioiodination the MAb retained their immunoreactivity and demonstrated a significantly higher in vitro binding with isolated M3-tumour cells as compared with a control antibody. B2C114 revealed 10(6) antigenic sites per cell, with a constant affinity of 5.1 x 10(9)/M. Biodistribution studies showed that B2C114 discriminated between malignant tumour and mouse normal tissues. Radioimmunodetection of Balb/c mice bearing s.c. M3-tumour showed that tumour was specifically defined without subtraction 1 day after injection of the radiolabelled antibody.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0883-2897
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
589-96
|
pubmed:dateRevised |
2008-2-21
|
pubmed:meshHeading |
pubmed-meshheading:1399688-ABO Blood-Group System,
pubmed-meshheading:1399688-Adenocarcinoma,
pubmed-meshheading:1399688-Animals,
pubmed-meshheading:1399688-Antibodies, Monoclonal,
pubmed-meshheading:1399688-Female,
pubmed-meshheading:1399688-Injections, Intraperitoneal,
pubmed-meshheading:1399688-Iodine Radioisotopes,
pubmed-meshheading:1399688-Mammary Neoplasms, Experimental,
pubmed-meshheading:1399688-Mice,
pubmed-meshheading:1399688-Mice, Inbred BALB C,
pubmed-meshheading:1399688-Tissue Distribution,
pubmed-meshheading:1399688-Tumor Cells, Cultured
|
pubmed:year |
1992
|
pubmed:articleTitle |
Specific biodetection of a murine spontaneous mammary carcinoma with labelled anti-human blood group-A monoclonal antibody.
|
pubmed:affiliation |
Oncologic Center of Nuclear Medicine, National Atomic Energy Commission, Buenos Aires, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|